- Home
- ADI vs PFE Comparison
ADI vs PFE Comparison
Compare ADI & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADI | PFE |
|---|---|---|
| Founded | 1965 | 1849 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 183.5B | 147.6B |
| IPO Year | 1994 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ADI | PFE |
|---|---|---|
| Price | $375.89 | $27.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 14 |
| Target Price | ★ $385.45 | $29.29 |
| AVG Volume (30 Days) | 3.8M | ★ 32.8M |
| Earning Date | 05-20-2026 | 05-05-2026 |
| Dividend Yield | 1.13% | ★ 6.55% |
| EPS Growth | ★ 39.02 | N/A |
| EPS | ★ 6.83 | 0.43 |
| Revenue | $6,200,942,000.00 | ★ $62,579,000,000.00 |
| Revenue This Year | $28.41 | N/A |
| Revenue Next Year | $10.25 | N/A |
| P/E Ratio | ★ $54.19 | $64.73 |
| Revenue Growth | ★ 21.41 | N/A |
| 52 Week Low | $223.47 | $23.59 |
| 52 Week High | $449.52 | $28.75 |
Technical Indicators
Market Signals| Indicator | ADI | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 46.91 | 69.96 |
| Support Level | $368.91 | $24.90 |
| Resistance Level | $404.53 | $28.75 |
| Average True Range (ATR) | 10.82 | 0.58 |
| MACD | 0.06 | 0.18 |
| Stochastic Oscillator | 24.53 | 87.15 |
Price Performance
Historical ComparisonAbout ADI Analog Devices Inc.
Analog Devices is a leading analog, mixed-signal, and digital-signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers; more than half of its chip sales are to industrial and automotive end markets. ADI's chips are also incorporated into wireless infrastructure equipment.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.